multiplex
polymeras
chain
reaction
pcr
base
diagnost
techniqu
allow
rapid
simultan
identif
broad
rang
respiratori
pathogen
compar
classic
microbiolog
diagnost
method
pcrbase
assay
offer
higher
sensit
specif
reproduc
howev
high
sensit
multiplex
pcr
diagnost
directli
translat
clinic
util
assay
distinguish
viabl
dead
organ
acut
infect
asymptomat
colonis
clinic
set
etiolog
agent
seldom
identifi
unspecif
respiratori
symptom
often
treat
empir
although
quantif
microbi
load
may
vari
depend
presenc
coinfect
specimen
type
sampl
techniqu
time
sampl
quantit
semiquantit
microbi
load
data
realtim
pcr
assay
may
help
defin
organ
densiti
consist
colon
infect
distinguish
symptomat
asymptomat
state
studi
assess
whether
semiquantit
microbi
load
availab
realtim
pcr
assay
differenti
symptomat
asymptomat
state
common
respiratori
agent
cohort
basic
militari
traine
two
royal
thai
armi
barrack
detail
studi
set
procedur
describ
previous
briefli
particip
recruit
six
consecut
cohort
basic
militari
traine
two
royal
thai
armi
barrack
may
juli
traine
enter
camp
train
period
start
may
novemb
year
individu
age
year
enter
one
two
armi
barrack
involv
studi
elig
enrol
suspect
tuberculosi
case
individu
immun
defici
acquir
immun
defici
syndrom
leukemia
lymphoma
exclud
throat
anterior
nasal
swab
sampl
collect
use
stiff
synthet
swab
train
studi
staff
start
end
train
period
nonacut
sampl
place
viral
transport
media
univers
transport
medium
copan
diagnost
store
time
transfer
arm
forc
research
institut
medic
scienc
test
addit
enrol
particip
ask
consult
camp
medic
unit
experienc
respiratori
symptom
train
period
medic
staff
took
histori
conduct
medic
exam
record
symptom
upper
respiratori
ill
uri
influenzalik
ill
ili
uri
defin
ill
least
two
follow
runni
nose
sneez
ii
nasal
congest
iii
sore
throat
hoars
difficulti
swallow
iv
cough
v
swollen
tender
gland
neck
vi
fever
oral
temperatur
ili
defin
respiratori
ill
acut
onset
present
fever
cough
sore
throat
throat
nasal
swab
sampl
collect
averag
day
symptom
onset
individu
develop
uri
ili
followup
acut
sampl
specimen
two
six
cohort
total
number
individu
test
use
commerci
multiplex
realtim
pcr
assay
compris
bacteri
viral
fungal
target
accord
manufactur
instruct
kit
fast
track
diagnost
eschsuralzett
luxembourg
two
cohort
select
underw
concurr
routin
environment
sampl
air
surfac
within
barrack
similarli
test
use
kit
data
shown
multiplex
test
specimen
remain
cohort
done
due
resourc
constraint
cycl
threshold
ct
valu
detect
limit
assay
consid
posit
result
nonacut
sampl
collect
end
train
period
particip
experienc
acut
episod
followup
exclud
analysi
ctvalu
might
reflect
postinfecti
shed
use
mcnemar
test
determin
whether
targetspecif
frequenc
significantli
differ
nonacut
baselin
sampl
acut
sampl
addit
comput
chisquar
fisher
exact
test
expect
valu
assess
whether
codetect
specif
microb
pair
occur
frequent
expect
chanc
nonacut
baselin
acut
sampl
account
data
censor
ctvalu
random
effect
tobit
regress
model
use
compar
ctvalu
distribut
nonacut
acut
sampl
ctvalu
distribut
sampl
contain
singl
multipl
organ
addit
use
kruskalw
test
compar
median
delay
ill
onset
sampl
collect
sampl
contain
one
multipl
organ
analys
conduct
use
stata
softwar
stata
corpor
studi
approv
institut
review
board
royal
thai
armi
bangkok
thailand
walter
reed
armi
institut
research
london
school
hygien
tropic
medicin
particip
provid
written
inform
consent
investig
adher
polici
protect
human
subject
prescrib
armi
regul
analyz
total
nonacut
swab
sampl
collect
recruit
start
n
end
n
train
period
acut
specimen
individu
develop
one
uri
episod
followup
target
contain
respiratori
panel
detect
least
one
specimen
tabl
virus
detect
bacteria
nonacut
sampl
among
acut
sampl
virus
detect
bacteria
specimen
haemophilu
influenza
type
b
hib
commonli
detect
microb
nonacut
acut
sampl
frequent
detect
bacteria
includ
nontyp
b
haemophilu
influenza
hinonb
streptococcu
pneumonia
klebsiella
pneumonia
tabl
rhinoviru
preval
viru
detect
nonacut
acut
sampl
virus
detect
collect
specimen
tabl
hinonb
rhinoviru
coronaviru
detect
significantli
less
frequent
nonacut
sampl
collect
start
train
period
acut
sampl
pvalu
tabl
influenza
b
identifi
none
nonacut
acut
specimen
multipl
microb
detect
nonacut
sampl
collect
start
train
period
codetect
multipl
organ
significantli
higher
nonacut
sampl
taken
end
train
period
acut
specimen
pvalu
tabl
among
acut
sampl
specif
organ
pair
codetect
frequent
expect
chanc
pvalu
tabl
fig
hib
identifi
togeth
hinonb
rhinoviru
acut
sampl
respect
codetect
influenza
b
viru
hinonb
occur
acut
sampl
remain
organ
pair
found
acut
specimen
tabl
microb
pair
occur
frequent
expect
chanc
among
nonacut
baselin
sampl
overal
substanti
overlap
ctvalu
distribut
nonacut
sampl
collect
start
end
train
period
acut
sampl
collect
symptomat
individu
followup
fig
case
even
consid
sampl
singl
organ
identifi
fig
hinonb
pneumonia
tobit
regress
model
indic
significantli
lower
microbi
load
nonacut
baselin
compar
acut
sampl
pvalu
tabl
hinonb
coeffici
repres
higher
averag
ctvalu
nonacut
baselin
sampl
compar
acut
specimen
correspond
approxim
lower
microbi
load
nonacut
compar
acut
sampl
pneumonia
averag
microbi
load
lower
nonacut
baselin
sampl
compar
acut
specimen
analysi
also
indic
significantli
lower
averag
rhinoviru
load
nonacut
sampl
collect
either
start
end
train
period
compar
acut
sampl
pvalu
tabl
contrast
hib
regress
analysi
indic
higher
averag
microbi
load
nonacut
baselin
sampl
compar
acut
sampl
pvalu
tabl
hinon
b
pneumonia
increas
averag
microbi
load
nonacut
sampl
collect
end
followup
compar
acut
sampl
collect
uri
episod
respect
pvalu
signific
differ
delay
symptom
onset
specimen
collect
acut
sampl
contain
one
median
delay
day
interquartil
rang
iqr
median
delay
day
iqr
organ
pvalu
six
acut
specimen
neg
agent
test
median
delay
day
iqr
thu
sampl
delay
unlik
account
observ
differ
ctvalu
distribut
analyz
pattern
infect
common
respiratori
agent
welldefin
popul
militari
recruit
use
highli
sensit
multiplex
pcr
diagnost
allow
accur
character
spectrum
organ
contain
nonacut
acut
sampl
data
indic
cocircul
sever
differ
viral
agent
high
frequenc
bacteri
colon
nonacut
acut
sampl
one
third
respiratori
ill
case
among
armi
personnel
reportedli
caus
viral
bacteri
infect
gather
individu
divers
geograph
locat
crowd
live
condit
increas
risk
microb
transmiss
set
ill
usual
selflimit
although
emerg
highli
virul
strain
lead
high
morbid
mortal
streptococcu
bacteria
adenovirus
coronavirus
influenza
among
wide
distribut
microb
militari
environ
implic
febril
ill
case
report
militari
medic
facil
identifi
organ
one
sampl
microb
overal
detect
frequenc
compar
nonacut
acut
sampl
although
influenza
b
coronaviru
commonli
identifi
among
acut
specimen
infecti
agent
commonli
circul
among
militari
personnel
includ
h
influenza
rhinoviru
lesser
extent
parainfluenza
rsv
l
pneumophila
although
presenc
necessarili
impli
occurr
clinic
symptom
h
influenza
rhinovirus
frequent
detect
organ
popul
nonacut
acut
sampl
detect
parainfluenza
l
pneumophila
find
rsv
sampl
individu
develop
uri
followup
ill
etiolog
could
unequivoc
determin
among
acut
sampl
hib
frequent
detect
organ
sole
agent
identifi
acut
specimen
codetect
microb
acut
sampl
howev
colonis
hib
also
common
among
nonacut
baselin
sampl
detect
alon
combin
microb
specimen
respect
organ
rare
detect
among
asymptomat
individu
frequent
found
acut
sampl
causal
associ
may
like
instanc
influenza
b
detect
none
nonacut
acut
sampl
similarli
proport
hinonb
rhinovirusposit
sampl
significantli
lower
among
nonacut
specimen
collect
baselin
compar
acut
sampl
howev
acut
sampl
posit
hinon
b
rhinoviru
influenza
b
also
posit
one
addit
microb
causal
associ
could
determin
agent
hinon
b
adenoviru
frequent
detect
nonacut
sampl
collect
end
followup
possibl
indic
postinfecti
shed
persist
infect
subclin
level
clinic
set
overlap
clinic
present
poor
capabl
determin
etiolog
respiratori
ill
often
lead
inappropri
treatment
broadspectrum
antibiot
might
occur
even
frequent
militari
set
molecular
diagnost
tool
usual
inaccess
sinc
consider
fraction
respiratori
ill
caus
virus
unsubstanti
use
antibiot
particularli
problemat
lead
neg
health
outcom
promot
develop
antimicrobi
resist
studi
evalu
impact
multiplex
diagnost
procedur
patient
manag
report
inconsist
result
outpati
set
access
rapid
molecular
diagnost
tool
respiratori
pathogen
significantli
reduc
antibiot
prescript
rate
patient
present
respiratori
ill
howev
find
confirm
hospit
set
pcrbase
test
fail
reduc
hospit
admiss
durat
hospit
stay
patient
acut
respiratori
infect
although
molecular
diagnost
tool
may
help
differenti
bacteri
viral
respiratori
agent
unlik
antibacteri
treatment
would
termin
base
mere
presenc
viral
agent
acut
respiratori
sampl
especi
consid
high
rate
bacteri
coinfect
quantit
semiquantit
diagnost
tool
potenti
help
defin
clinic
signific
pathogen
densiti
proven
highli
valuabl
understand
dynam
diarrheal
diseas
improv
manag
gastrointestin
ill
among
acut
diarrhea
patient
quantit
amplif
noroviru
rna
fecal
sampl
help
determin
pathogen
load
threshold
effect
distinguish
causal
associ
subpathogen
carriag
similarli
rotaviru
load
correl
diseas
sever
among
children
gastroenter
crucial
role
microbi
replic
viral
pathogenesi
valu
pathogen
load
quantit
could
clearli
establish
gastrointestin
ill
viral
etiolog
although
evid
avail
bacteri
infect
well
instanc
microbi
load
enteropathogen
e
coli
significantli
higher
among
children
diarrhea
compar
control
subject
especi
enteropathogen
e
coli
sole
agent
identifi
studi
tobit
regress
indic
significantli
lower
microbi
load
nonacut
rel
acut
sampl
rhinoviru
hinonb
pneumonia
howev
due
substanti
overlap
ctvalu
distribut
possibl
identifi
ctvalu
threshold
indic
causal
organ
previou
studi
assess
associ
viral
load
clinic
symptom
respiratori
infect
report
similar
find
mean
viral
load
rhinoviru
six
addit
virus
significantli
higher
upper
respiratori
tract
aspir
children
pneumonia
compar
healthi
control
overlap
viral
load
distribut
substanti
pediatr
patient
high
rhinoviru
load
associ
presenc
lower
respiratori
tract
symptom
threshold
clinic
relev
could
determin
rhinoviru
sole
agent
identifi
addit
studi
report
correl
microbi
load
occurr
sever
respiratori
symptom
rsv
bocaviru
human
metapneumoviru
hmpv
although
find
inconsist
condit
presenc
viru
singl
microb
detect
signific
associ
microbi
load
clinic
manifest
virus
rhinoviru
h
influenza
streptococcu
speci
previou
studi
report
signific
correl
bacteri
densiti
clinic
manifest
diseas
young
patient
acut
respiratori
tract
infect
pneumonia
load
fluctuat
symptom
incid
resolut
among
children
hospit
pneumonia
median
nasopharyng
pneumonia
load
substanti
higher
compar
healthi
control
pneumococc
densiti
also
associ
sever
symptom
increas
durat
children
hospit
stay
similar
associ
observ
pneumon
adult
although
correl
signific
popul
associ
microbi
load
clinic
manifest
may
depend
specif
pathogenhost
interact
pathogenesi
primarili
relat
microbi
replic
stronger
correl
microbi
load
ill
magnitud
may
observ
clinic
manifest
larg
attribut
host
immun
defenc
bacteri
toxin
correl
microbi
load
may
obviou
tempor
variat
microbi
load
may
also
play
import
role
quantiti
nucleic
acid
significantli
abund
time
locat
patholog
acut
respiratori
ill
patient
high
bacteri
colon
densiti
often
associ
presenc
viral
coinfect
clinic
manifest
may
vari
depend
specif
coinfect
pattern
ecolog
respiratori
pathogen
also
like
influenc
live
condit
militari
set
mix
individu
divers
background
live
closequart
high
level
interperson
contact
increas
potenti
introduct
spread
multipl
microb
popul
could
account
broad
rang
organ
codetect
studi
analys
nonacut
acut
sampl
close
monitor
popul
semiclos
longitudin
set
studi
popul
welldefin
rel
homogen
regard
demograph
live
condit
howev
find
may
applic
popul
differ
sociodemograph
characterist
popul
outsid
militari
environ
cohort
children
among
impact
respiratori
infect
may
greater
frequent
codetect
multipl
respiratori
agent
failur
distinguish
viabl
dead
organ
microb
colon
host
subpathogen
level
may
prevent
unambigu
interpret
test
result
posit
result
may
indic
ill
aetiolog
asymptomat
colonis
postinfecti
shed
incipi
infect
therefor
ctvalu
may
alway
reliabl
surrog
infecti
load
sampl
two
six
cohort
test
realtim
pcr
although
might
bia
season
effect
usual
less
pronounc
tropic
given
rel
low
frequenc
viral
detect
larger
sampl
size
longer
followup
may
captur
precis
pictur
infect
pattern
popul
studi
also
limit
detect
organ
contain
respiratori
panel
exclud
presenc
addit
organ
specimen
addit
data
obtain
throat
nasal
swab
sampl
find
may
appli
nasopharyng
sputum
specimen
final
qualiti
quantiti
materi
obtain
nose
throat
swab
may
differ
significantli
among
subject
success
pcrbase
method
also
depend
avail
intact
genom
sequenc
absenc
random
mutat
overal
multiplex
respiratori
panel
provid
comprehens
character
microb
spectrum
contain
nonacut
acut
respiratori
sampl
collect
among
recruit
howev
semiquantit
assess
microbi
load
could
reliabl
distinguish
symptomat
asymptomat
sampl
research
warrant
compar
new
multiplex
diagnost
techniqu
tradit
method
evalu
potenti
regard
diagnost
accuraci
clinic
util
context
respiratori
infect
